Periodic Reporting for period 3 - TUMOURPRINT (High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research)

CELLINK will develop and commercialise TumourPrint - a high throughput platform for bioprinting of live tumour models for pharmaceutical drug development and large-scale cancer research. Bioprinting constitutes the most advanced method for fabricating fidel tissue models...